Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 11, 2025 02:00 ET | Source: GEVORKYAN, a.s.

GEVORKYAN stock analysis: Target Price CZK 321, Growth up to +40%

"Using our DCF model and a calculated WACC of 6,9 %, we determine a fair value of CZK 300 and a 12-month price target of CZK 321," notes Dr. Kalliwoda Research GmbH in analytical report GEVORKYAN,...
November 04, 2025 01:00 ET | Source: GEVORKYAN, a.s.

GEVORKYAN stock analysis: Target price +53% up to 330 CZK

"Applying standard valuation multiples to the annualized H1 2025 results, the fair value of the share is estimated to range between 310 CZK and 330 CZK, indicating that the current market price does...
May 16, 2017 09:00 ET | Source: AXIM Biotechnologies, Inc

SeeThruEquity Initiates Coverage on AXIM® Biotech (OTC: AXIM) With a Target Price of $17.0

NEW YORK, May 16, 2017 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that SeeThruEquity, a...
September 11, 2012 03:01 ET | Source: DataSift

DataSift Launches Social Feeds for the Financial Services Industry

SAN FRANCISCO, CA--(Marketwire - Sep 11, 2012) - DataSift (http://www.datasift.com/), the social data platform company, today launched DataSift Financial, a prepackaged historical and real-time...